Tray Thomas

Tray Thomas serves as the Principal Accounting Officer at Incyte Corporation, a biopharmaceutical company focused on discovering and developing innovative medicines for cancer and other serious diseases. His recent trading activity, documented through SEC Form 4 filings, reveals a pattern of sale activity from January 22, 2025, to July 7, 2026, exclusively involving Incyte Corporation (INCY). Over this period, he has disclosed 17 transactions, with the largest sale valued at approximately $277.4K on December 22, 2025.